This sample demonstrates a co-branded patient education asset developed by Verivance MedComms in collaboration with a fictitious brand, Cardiova™ (Empagliflozin).
It empowers doctors to speak clearly and compassionately with patients while ensuring adherence and trust, all within regulatory-safe, emotionally intelligent messaging.